Library Item Posts on Medivizor
Navigation Menu

Library Item Posts on Medivizor

Evaluating the safety of EPOCH-R therapy for patients with non-Hodgkin’s lymphoma

Posted by on Jan 15, 2019 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study investigated complications associated with reduced-intensity EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, rituximab) therapy for patients with non-Hodgkin’s lymphoma (NHL). This study concluded that this treatment was associated with high rates of drug delivery complications. Some background...

Read More

Lymphocyte count reduction is associated with better rectal cancer outcomes

Posted by on Jan 13, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the relationship between lymphocyte (a type of white blood cells) counts and treatment outcomes for patients with rectal cancer. Researchers suggested that lymphocyte count reduction may be caused by rectal cancer treatment and is associated with better tumor response. Some background Colorectal cancer is the...

Read More

Intense physical exercise therapy improves symptoms in patients with Parkinson’s disease

Posted by on Jan 13, 2019 in Parkinson's Disease | 0 comments

In a nutshell This study investigated the effects of exercise therapy to treat the symptoms of patients with Parkinson disease. Researchers suggested that exercise therapy improved the symptoms of these patients in a short-term period. Some background Parkinson disease is a progressive disease that affects brain cells. It causes impaired movements and...

Read More

Anti-vascular endothelial growth factor (anti-VEGF) drugs for diabetic eye disease

Posted by on Jan 13, 2019 in Diabetes mellitus | 0 comments

In a nutshell The aim of this study was to evaluate anti-vascular endothelial growth factor (anti-VEGF) drugs for diabetic macular oedema. The main finding of the study was that these drugs prevent loss of sight and improve vision in these patients. Some background Patients with diabetes are at risk of developing an eye disease called...

Read More

Diastolic blood pressure can predict the size of plaque in heart blood vessels

Posted by on Jan 13, 2019 in Coronary artery disease | 0 comments

In a nutshell The aim of this study was to investigate the relationship between blood pressure and plaque size in coronary (heart) blood vessels. The main finding of the study was that diastolic (the second number in the blood pressure reading) blood pressure can predict the size of the coronary plaque. Some background High blood pressure is a major...

Read More

Can the DASH diet decrease the risk of stroke?

Posted by on Jan 13, 2019 in Stroke | 0 comments

In a nutshell This study aimed to see if the DASH diet (Dietary Approaches to Stop Hypertension) could reduce the risk of stroke. The main finding of the study was that adherence to the DASH decreased the risk of stroke. Some background The Dietary Approaches to Stop Hypertension (DASH) diet was developed in 1997. It consists of 8 components: high...

Read More

Can the DASH diet decrease the risk of stroke?

Posted by on Jan 13, 2019 in Hypertension | 0 comments

In a nutshell This study aimed to see if the DASH diet (Dietary Approaches to Stop Hypertension) could reduce the risk of stroke. The main finding of the study was that adherence to the DASH decreased the risk of stroke. Some background The Dietary Approaches to Stop Hypertension (DASH) diet was developed in 1997. It consists of 8 components: high...

Read More

Brigatinib versus Crizotinib in ALK-Positive Non-Small-Cell Lung Cancer.

Posted by on Jan 12, 2019 in Lung cancer | 0 comments

In a nutshell This study wanted to find out if the medication brigatinib (Alunbrig) is better than crizotinib (Xalkori) in treating patients with lung cancer. The study found that survival was significantly longer in patients who were treated with brigatinib compared to those treated with crizotinib. Some background Brigatinib and crizotinib are a...

Read More

What are the effects of lenalidomide, doxorubicin, vinblastine and dacarbazine in Hodgkin lymphoma?

Posted by on Jan 12, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study investigated the effects of adding lenalidomide (Revlimid) to doxorubicin (Adriamycin), vinblastine (Velban), and dacarbazine (DTIC-Dome) treatment for older patients with Hodgkin lymphoma (HL). The main finding was that this combination is effective but severe side-effects may be experienced. Some background HL is a cancer...

Read More

Risk factors for developing urinary incontinence after Holmium Laser Enucleation

Posted by on Jan 12, 2019 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study looked at factors which may cause incontinence after laser breakdown of prostate tissue. It concluded that pre-existing incontinence or weak urinary muscles could cause incontinence after the laser procedure.  Some background Benign Prostatic Hyperplasia (BPH) is a non-cancerous enlargement of the prostate...

Read More